Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Oncological Medicine
Volume 2015, Article ID 351431, 5 pages
http://dx.doi.org/10.1155/2015/351431
Case Report

Lymphocyte-Predominant Hodgkin’s Disease in Children: A Case Study and Review of the Literature

1Department of Pediatrics, Tulane University School of Medicine, New Orleans, LA 70112, USA
2Department of Pediatrics, Ochsner Health System, New Orleans, LA 70112, USA
3Department of Pediatrics, Tulane University School of Medicine, New Orleans, LA 70112, USA
4Department of Pediatric Hematology-Oncology, Ochsner Health System, New Orleans, LA 70121, USA
5University of Queensland School of Medicine, Brisbane, QLD 4006, Australia

Received 2 January 2015; Revised 26 February 2015; Accepted 10 March 2015

Academic Editor: Nurdan Tacyildiz

Copyright © 2015 James R. Stier and Robert J. Vasquez. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. A. Eichenauer, M. Fuchs, A. Pluetschow et al., “Phase 2 study of rituximab in newly diagnosed stage IA nodular lymphocytepredominant Hodgkin lymphoma: a report from the German Hodgkin Study Group,” Blood, vol. 118, no. 16, pp. 4363–4365, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. V. Diehl, M. Sextro, J. Franklin et al., “Clinical presentation, course, and prognostic factors in lymphocyte- predominant Hodgkin's disease and lymphocyte-rich classical Hodgkin's disease: report from the European Task Force on lymphoma project on lymphocyte-predominant Hodgkin's disease,” Journal of Clinical Oncology, vol. 17, no. 3, pp. 776–783, 1999. View at Google Scholar · View at Scopus
  3. I. Biasoli, A. Stamatoullas, V. Meignin et al., “Nodular, lymphocyte-predominant Hodgkin lymphoma: a long-term study and analysis of transformation to diffuse large B-cell lymphoma in a cohort of 164 patients from the adult lymphoma study group,” Cancer, vol. 116, no. 3, pp. 631–639, 2010. View at Google Scholar · View at Scopus
  4. L. Nogová, T. Reineke, C. Brillant et al., “Lymphocyte-predominant and classical Hodgkin's lymphoma: a comprehensive analysis from the german Hodgkin study group,” Journal of Clinical Oncology, vol. 26, no. 3, pp. 434–439, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. C. L. Schwartz, “Special issues in pediatric Hodgkin's disease,” European Journal of Haematology, vol. 75, supplement 66, pp. 55–62, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Punnett, R. W. Tsang, and D. C. Hodgson, “Hodgkin lymphoma across the age spectrum: epidemiology, therapy, and late effects,” Seminars in Radiation Oncology, vol. 20, no. 1, pp. 30–44, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Shankar, G. W. Hall, S. Gorde-Grosjean et al., “Treatment outcome after low intensity chemotherapy [CVP] in children and adolescents with early stage nodular lymphocyte predominant Hodgkin's lymphoma—an Anglo-French collaborative report,” European Journal of Cancer, vol. 48, no. 11, pp. 1700–1706, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. P. M. Mauch, L. A. Kalish, M. Kadin, C. N. Coleman, R. Osteen, and S. Hellman, “Patterns of presentation of Hodgkin disease: implications for etiology and pathogenesis,” Cancer, vol. 71, no. 6, pp. 2062–2071, 1993. View at Publisher · View at Google Scholar · View at Scopus
  9. I. A. Lee and A. S. LaCasce, “Nodular lymphocyte predominant hodgkin lymphoma,” The Oncologist, vol. 14, no. 7, pp. 739–751, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Shankar and S. Daw, “Nodular lymphocyte predominant Hodgkin lymphoma in children and adolescents—a comprehensive review of biology, clinical course and treatment options,” British Journal of Haematology, vol. 159, no. 3, pp. 288–298, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. R. Küppers, “Molecular biology of Hodgkin lymphoma,” Hematology/American Society of Hematology. Education Program, vol. 2009, no. 1, pp. 491–496, 2009. View at Google Scholar · View at Scopus
  12. S. H. Swerdlow, E. Campo, N. L. Harris et al., Eds., World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues, World Health Organization, Geneva, Switzerland, 4th edition, 2008.
  13. S. Prakash, T. Fountaine, M. Raffeld, E. S. Jaffe, and S. Pittaluga, “IgD positive L&H cells identify a unique subset of nodular lymphocyte predominant Hodgkin lymphoma,” American Journal of Surgical Pathology, vol. 30, no. 5, pp. 585–592, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. A. R. Huppmann, A. Nicolae, G. W. Slack et al., “EBV may be expressed in the LP cells of nodular lymphocyte-predominant hodgkin lymphoma (NLPHL) in both children and adults,” The American Journal of Surgical Pathology, vol. 38, no. 3, pp. 316–324, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Hartmann, D. A. Eichenauer, A. Plütschow et al., “Histopathological features and their prognostic impact in nodular lymphocyte-predominant Hodgkin lymphoma—a matched pair analysis from the German Hodgkin Study Group (GHSG),” British Journal of Haematology, vol. 167, no. 2, pp. 238–242, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. L. Nogová, T. Reineke, C. Brillant et al., “Lymphocyte-predominant and classical Hodgkin's lymphoma: a comprehensive analysis from the german Hodgkin study group,” Journal of Clinical Oncology, vol. 26, no. 3, pp. 434–439, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. Z. Fan, Y. Natkunam, E. Bair, R. Tibshirani, and R. A. Warnke, “Characterization of variant patterns of nodular lymphocyte predominant Hodgkin lymphoma with immunohistologic and clinical correlation,” American Journal of Surgical Pathology, vol. 27, no. 10, pp. 1346–1356, 2003. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Hartmann, D. A. Eichenauer, A. Plütschow et al., “The prognostic impact of variant histology in nodular lymphocyte-predominant Hodgkin lymphoma: a report from the German Hodgkin Study Group (GHSG),” Blood, vol. 122, no. 26, pp. 4246–4252, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. C. Mauz-Körholz, S. Gorde-Grosjean, D. Hasenclever et al., “Resection alone in 58 children with limited stage, lymphocyte-predominant Hodgkin lymphoma-experience from the European network group on pediatric Hodgkin lymphoma,” Cancer, vol. 110, no. 1, pp. 179–185, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. B. Pellegrino, M. J. Terrier-Lacombe, O. Oberlin et al., “Lymphocyte-predominant Hodgkin's lymphoma in children: therapeutic abstention after initial lymph node resection—astudy of the French Society of Pediatric Oncology,” Journal of Clinical Oncology, vol. 21, no. 15, pp. 2948–2952, 2003. View at Publisher · View at Google Scholar · View at Scopus
  21. B. E. Appel, L. Chen, A. Buxton, S. L. Wolden, D. C. Hodgson, and J. B. Nachman, “Impact of low-dose involved-field radiation therapy on pediatric patients with lymphocyte-predominant Hodgkin lymphoma treated with chemotherapy: a report from the Children's Oncology Group,” Pediatric Blood & Cancer, vol. 59, no. 7, pp. 1284–1289, 2012. View at Publisher · View at Google Scholar
  22. M. L. Metzger, H. J. Weinstein, M. M. Hudson et al., “Association between radiotherapy vs no radiotherapy based on early response to VAMP chemotherapy and survival among children with favorable-risk Hodgkin lymphoma,” Journal of the American Medical Association, vol. 307, no. 24, pp. 2609–2616, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. S. S. Donaldson, M. P. Link, H. J. Weinstein et al., “Final results of a prospective clinical trial with VAMP and low-dose involved-field radiation for children with low-risk Hodgkin's disease,” Journal of Clinical Oncology, vol. 25, no. 3, pp. 332–337, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. C. K. Tebbi, N. P. Mendenhall, W. B. London et al., “Response-dependent and reduced treatment in lower risk Hodgkin lymphoma in children and adolescents, results of P9426: a report from the Children's Oncology Group,” Pediatric Blood & Cancer, vol. 59, no. 7, pp. 1259–1265, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. C. Jackson, B. Sirohi, D. Cunningham, A. Horwich, K. Thomas, and A. Wotherspoon, “Lymphocyte-predominant Hodgkin lymphoma—clinical features and treatment outcomes from a 30-year experience,” Annals of Oncology, vol. 21, no. 10, pp. 2061–2068, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. H. Schulz, U. Rehwald, F. Morschhauser et al., “Rituximab in relapsed lymphocyte-predominant Hodgkin lymphoma: long-term results of a phase 2 trial by the German Hodgkin Lymphoma Study Group (GHSG),” Blood, vol. 111, no. 1, pp. 109–111, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. R. H. Advani, S. J. Horning, R. T. Hoppe et al., “Mature results of a phase II study of rituximab therapy for nodular lymphocyte-predominant Hodgkin lymphoma,” Journal of Clinical Oncology, vol. 32, no. 9, pp. 912–918, 2014. View at Publisher · View at Google Scholar · View at Scopus